# User Fee Waivers, Reductions, and Refunds for Drug and Biological Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/user-fee-waivers-reductions-and-refunds-for-drug-and-biological-products/ff74c3d1-95d4-4808-9bba-25a26706e7e4

> FDA guidance document: User Fee Waivers, Reductions, and Refunds for Drug and Biological Products. Issue date: September 27, 2011. Get complete insights and analysis.

---

## Details

- Title: User Fee Waivers, Reductions, and Refunds for Drug and Biological Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2011-09-27
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0108">FDA-2011-D-0108</a>

## Related Documents

- [Expedited Programs for Serious Conditions | Drugs and Biologics](https://www.globalkeysolutions.net/guidances/guidance-document/expedited-programs-for-serious-conditions-drugs-and-biologics/d49c172d-43db-4e76-a0fd-1f51de9ecff3)
- [Safety Labeling Changes -- Implementation of Section 505(o)(4) of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/safety-labeling-changes-implementation-of-section-505o4-of-the-federal-food-drug-and-cosmetic-act/2ee1cd52-3926-4b4e-8acb-2ae6e7eea9c8)
- [Dear Health Care Provider Letters: Improving Communication of Important Safety Information](https://www.globalkeysolutions.net/guidances/guidance-document/dear-health-care-provider-letters-improving-communication-of-important-safety-information/a3ea6356-848d-4286-86e9-8ac6013377e1)